OPM's subsidiary passes EU QP audit
I'm PortAI, I can summarize articles.
OPM's wholly-owned subsidiary, Shanghai Silun Biotechnology Co., Ltd., recently successfully passed the European Union Quality Authorised Person (QP) audit and received a compliance audit report. This marks that Silun Biotechnology's quality management system meets the requirements of EU GMP regulations, providing assurance for its research and production services in the field of macromolecular biopharmaceuticals, and laying the foundation for expanding into international markets such as the EU
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments